# Tenax Therapeutics, Inc.: Form 8-K, filed Jul 31, 2026

- Company: [Tenax Therapeutics, Inc.](/companies/tenx.md) (CIK 34956)
- Form: 8-K
- Filed: 2026-07-31
- Accepted by EDGAR: Jul 31, 2026, 07:23 ET
- Period: 2026-07-31
- Accession: 0001193125-26-326784
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/34956/000119312526326784/d90330d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/34956/000119312526326784/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/34956/000119312526326784/d90330d8k.htm

Filed Jul 31, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-326784. Last ingested by Listed: Nov 5, 2026, 17:05 ET. No prices; not investment advice.